Antipodes
Antipodes Global Value Fund (PIE)
Sep 2026 → Sep 2026
Our archive holds 1 letter from this strategy, behind 1 investment thesis and positions in 16 companies. Every quote below is copied verbatim from the letter it came from.
1 letter in a year · follow all of Antipodes for every strategy.
What it bought and sold
Topping up reflects an accelerating AI-and-cloud engine that the depressed valuation under- rates.
We exited the position in the Japanese wafer fabrication equipment maker on valuation grounds after an exceptional period of performance.
Biogen Inc (Entry): Biogen is at a turning point where its growth products are now expected to more than offset declines in its legacy multiple sclerosis (MS) business.
We exited German utility RWE on valuation grounds after a strong period helped by normalised wind conditions, higher capacity payments and a larger stake in grid operator Amprion.
Analog and mixed-signal semiconductor manufacturer Skyworks pairs a diversification turnaround with a consolidation catalyst.
We trimmed Merck over the Quarter following a period of solid performance and as shares approached our valuation target.
We exited building products manufacturer Owens Corning (OC) as our margin of safety narrowed following positive price performance.
We initiated a position in Samsung following the sell-off.